Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.

Diffley M, Armenian P, Gerona R, Reinhartz O, Avasarala K.

Crit Care Med. 2012 Jul;40(7):2223-6. doi: 10.1097/CCM.0b013e318250a870.

PMID:
22584762
2.

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.

Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA.

Circulation. 2001 Jan 16;103(2):196-200.

3.

Deadly proposal: a case of catecholaminergic polymorphic ventricular tachycardia.

Heiner JD, Bullard-Berent JH, Inbar S.

Pediatr Emerg Care. 2011 Nov;27(11):1065-8. doi: 10.1097/PEC.0b013e3182360606.

PMID:
22068070
4.

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.

Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, Klug D, Hayashi M, Takatsuki S, Villain E, Kamblock J, Messali A, Guicheney P, Lunardi J, Leenhardt A.

Circulation. 2009 May 12;119(18):2426-34. doi: 10.1161/CIRCULATIONAHA.108.829267. Epub 2009 Apr 27.

5.

Catecholaminergic polymorphic ventricular tachycardia in a child: a case report.

Garabedian L, Verryckt A, Panzer J, De Wolf D.

Acta Paediatr. 2008 Jan;97(1):127-9. Epub 2007 Dec 3.

PMID:
18052993
6.
7.
8.

A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.

Aizawa Y, Ueda K, Komura S, Washizuka T, Chinushi M, Inagaki N, Matsumoto Y, Hayashi T, Takahashi M, Nakano N, Yasunami M, Kimura A, Hiraoka M, Aizawa Y.

Int J Cardiol. 2005 Mar 18;99(2):343-5.

PMID:
15749201
9.

High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.

Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Früh A, Edvardsen T, Kongsgård E, Leren TP, Amlie JP.

Europace. 2010 Mar;12(3):417-23. doi: 10.1093/europace/eup448. Epub 2010 Jan 26.

PMID:
20106799
10.

Catecholaminergic polymorphic ventricular tachycardia.

Liu N, Ruan Y, Priori SG.

Prog Cardiovasc Dis. 2008 Jul-Aug;51(1):23-30. doi: 10.1016/j.pcad.2007.10.005. Review.

PMID:
18634915
11.

[Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease].

Holst AG, Tfelt-Hansen J, Olesen MS, Theilade J, Winkel BG, Christensen AH, Bundgaard H, Haunsø S, Svendsen JH.

Ugeskr Laeger. 2010 Aug 2;172(31):2140-4. Review. Danish.

PMID:
20670590
12.

Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia.

Marjamaa A, Laitinen-Forsblom P, Lahtinen AM, Viitasalo M, Toivonen L, Kontula K, Swan H.

BMC Med Genet. 2009 Feb 12;10:12. doi: 10.1186/1471-2350-10-12.

13.

Novel ryanodine receptor 2 mutation associated with a severe phenotype of catecholaminergic polymorphic ventricular tachycardia.

LaPage MJ, Russell MW, Bradley DJ, Dick M 2nd.

J Pediatr. 2012 Aug;161(2):362-4. doi: 10.1016/j.jpeds.2012.04.013. Epub 2012 May 19.

PMID:
22608700
14.
15.

A de novo novel cardiac ryanodine mutation (Ser4155Tyr) associated with catecholaminergic polymorphic ventricular tachycardia.

Mantziari L, Vassilikos V, Anastasakis A, Kotsaka X, Paraskevaidis S, Styliadis IH, Luria D.

Ann Noninvasive Electrocardiol. 2013 Nov;18(6):571-6. doi: 10.1111/anec.12089. Epub 2013 Oct 23.

PMID:
24147812
16.

Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.

Nyegaard M, Overgaard MT, Søndergaard MT, Vranas M, Behr ER, Hildebrandt LL, Lund J, Hedley PL, Camm AJ, Wettrell G, Fosdal I, Christiansen M, Børglum AD.

Am J Hum Genet. 2012 Oct 5;91(4):703-12. doi: 10.1016/j.ajhg.2012.08.015.

17.

A novel mutation (Arg169Gln) of the cardiac ryanodine receptor gene causing exercise-induced bidirectional ventricular tachycardia.

Hsueh CH, Weng YC, Chen CY, Lin TK, Lin YH, Lai LP, Lin JL.

Int J Cardiol. 2006 Apr 4;108(2):276-8.

PMID:
16517285
18.

Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest.

Campbell MJ, Czosek RJ, Hinton RB, Miller EM.

Am J Med Genet A. 2015 Sep;167A(9):2197-200. doi: 10.1002/ajmg.a.37140. Epub 2015 May 27.

PMID:
26018045
19.

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, Dubosq-Bidot L, Sebillon P, Mannens MM, Guicheney P, Wilde AA.

J Med Genet. 2005 Nov;42(11):863-70.

20.

Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia.

Pflaumer A, Davis AM.

Heart Lung Circ. 2012 Feb;21(2):96-100. doi: 10.1016/j.hlc.2011.10.008. Epub 2011 Nov 25. Review.

PMID:
22119737

Supplemental Content

Support Center